Chemoinformaics analysis of HEDERAGENIN-3-O-ARABINOSIDE
| Molecular Weight | 604.825 | nRot | 4 |
| Heavy Atom Molecular Weight | 548.377 | nRig | 33 |
| Exact Molecular Weight | 604.398 | nRing | 6 |
| Solubility: LogS | -3.51 | nHRing | 1 |
| Solubility: LogP | 3.948 | No. of Aliphatic Rings | 6 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 5 |
| Atoms Count | 99 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 43 | No. of Aromatic Carbocycles | 0 |
| nHetero | 8 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 4 |
| No. of Hydrogen atom | 56 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 35 | No. of Saturated Rings | 5 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 8 | No. of Arom Bond | 0 |
| nHA | 7 | APOL | 102.206 |
| nHD | 5 | BPOL | 60.5196 |
| QED | 0.231 |
| Synth | 5.269 |
| Natural Product Likeliness | 3.125 |
| NR-PPAR-gamma | 0.919 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.004 |
| Pgp-sub | 0 |
| HIA | 0.201 |
| CACO-2 | -5.392 |
| MDCK | 0.0000181 |
| BBB | 0.138 |
| PPB | 0.971765 |
| VDSS | 0.825 |
| FU | 0.0500968 |
| CYP1A2-inh | 0.001 |
| CYP1A2-sub | 0.557 |
| CYP2c19-inh | 0.002 |
| CYP2c19-sub | 0.878 |
| CYP2c9-inh | 0.012 |
| CYP2c9-sub | 0.146 |
| CYP2d6-inh | 0.002 |
| CYP2d6-sub | 0.15 |
| CYP3a4-inh | 0.072 |
| CYP3a4-sub | 0.091 |
| CL | 1.12 |
| T12 | 0.036 |
| hERG | 0.002 |
| Ames | 0.092 |
| ROA | 0.087 |
| SkinSen | 0.005 |
| Carcinogencity | 0.049 |
| EI | 0.006 |
| Respiratory | 0.909 |
| NR-Aromatase | 0.857 |
| Antiviral | Yes |
| Prediction | 0.787474 |